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Summary 
A central issue in nitric oxide (NO) research is to understand how NO can act in some settings 
as a servoregulator  and in others as a cytotoxin. To answer this, we have sought a molecular 
basis for the differential regulation of the two known types of NO synthase (NOS). Constitutive 
NOS's in endothelium and neurons are activated by agonist-induced  elevation of Ca  2+  and 
resultant binding of calmodulin (CaM). In contrast, NOS in macrophages does not require added 
Ca  2+ or CaM, but is regulated instead by transcription.  We show here that macrophage NOS 
contains, as a tightly bound subunit, a molecule with the immunologic  reactivity, high performance 
liquid chromatography retention time, tryptic map, partial amino add sequence, and exact molecular 
mass of CaM. In contrast to most CaM-dependent enzymes, macrophage NOS binds CaM tightly 
without a requirement for elevated Ca  ~+ . This may explain why NOS that is independent of 
Ca  2+  and elevated CaM appears to be activated simply by being synthesized. 
A 
central question in nitric oxide (NO) research is to un- 
derstand how diverse physiologic roles can be subserved 
by the same radical gas acting alternatively as an intercellular 
servoregulator or a cytotoxin (1-5). In large part this reflects 
the differential distribution of two major classes of NO syn- 
thases (NOS's) distinguished on the basis of their expression 
and regulation. NOS's of one type, expressed constitutively 
in endothelial cells or neurons, respond in a ceU-type selec- 
tive manner to agonists that elevate intracellular Ca  2  +. NO 
production by these NOS's,  like the Ca  2+  transient itself, 
lasts for seconds  or minutes, and depends on calmodulin (CaM) 
(6, 7), a protein that transduces Ca  2+  signals by means of 
its  reversible, Ca2+-dependent  binding to  target enzymes 
and their resultant activation (8-10). We have termed these 
constitutive enzymes cNOS's to signify their dependence on 
Ca  2  + and CaM (1, 11). In contrast, catalysis by the immuno- 
logically inducible  iNOS is independent of Ca  2  + and ele- 
vated CaM (12, 13). Instead, expression ofiNOS activity ap- 
pears to be controlled chiefly at the level of transcription of 
the gene encoding it (11). Not only is iNOS activated more 
slowly than cNOS's, but catalysis  by iNOS continues for hours 
or days, leading to the production of much more NO than 
from an equivalent number of cells expressing cNOS. Ac- 
cordingly, while cNOS's are key regulators  of homeostasis 
in the circulatory, renal, pulmonary, gastrointestinal,  endo- 
crine, and nervous systems, iNOS appears to play an impor- 
tant role in cytotoxic and suppressive functions in the im- 
mune system and in toxic states such as septic shock (1-5). 
In the present study, we have restated the central question 
as follows. What is the molecular basis for the differential 
response to Ca  2  + and CaM by iNOS and cNOS? The en- 
zymes are "~51% identical at the amino acid level, and each 
contains a region rich in basic and hydrophobic residues that 
is structurally similar to known CaM-binding domains in 
other proteins (11, 14-16). Nonetheless, the activity of  purified 
iNOS is neither enhanced by exogenous CaZ+/CaM, nor in- 
hibited by chdators of divalent cations or drugs that block 
the binding of CaM to its targets (12, 13). This paradox could 
be resolved if CaM did not require an devation in Ca  2  + to 
bind tightly to iNOS. Endogenous CaM might then copu- 
rify with iNOS, resist displacement by CaM inhibitors,  and 
maintain iNOS in a tonically activated state. 
Materials and Methods 
Ca  2+ concentrations were measured using a graphite furnace 
atomic absorption  photometer (Zeeman/3030;  Perkin-Elraer,  Inc., 
Norwalk, CT) (17). Other methods are detailed or cited in the 
legends or text. 
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CaM-like Antigen in Purified iNOS.  Purified  as a 260--290- 
kD dimer, iNOS migrated on SDS-PAGE as a doublet at 130 
kD (Fig.  1, lane 1), as previously reported (12). No species 
in the region of CaM (16.8 kD) was visible upon staining 
with amido black (Fig 1, lane I),  silver (12) or coomassie 
blue (H. Cho, et al.,  unpublished observations). However, 
CaM is reportedly difficult to visualize by conventional staining 
methods (18). In our hands, reagent bovine brain CaM (0.5 
/,g/lane) was undetectable upon staining with amido black 
(Fig.  1, lane 2) or coomassie blue, and hard to stain by silver 
(H. Cho, unpublished observations). Thus, apparently pure 
iNOS might nonetheless contain CaM. 
To look for CaM in pure, enzymaticaUy active iNOS prepa- 
rations by a more sensitive  method, we made use of anti- 
CaM antibody. Using the COOH-terminal 20 amino acids 
of CaM coupled to thyroglobulin, Sacks et al. (19) were able 
to raise a mAb that binds CaM with an affinity of 5  x  10  s 
liter/tool  and  does  not  crossreact  with  the  homologous 
Ca2+-binding proteins troponin C,  S100tx, S100B, or par- 
valbumin. This highly specific mAb reacted  with two an- 
tigens in an immunoblot of purified iNOS (Fig.  1, lane 3). 
The lower molecular mass bands comigrated with authentic 
CaM (Fig. 1, lane 4). Surprisingly, the iNOS doublet "~130 
kD was also reactive. 
The foregoing results raised three questions. (a) Did the 
CaM-like antigen (that is, the molecule reactive with anti- 
CAM mAb and migrating with the same apparent molec- 
ular mass as CaM) copurify with the iNOS adventiously, or 
was it tightly bound to the enzyme? (b) Did the additional 
reactivity of anti-CaM mAb with 130-kD iNOS monomer 
reflect a covalent association  of a portion of the CaM with 
iNOS? And, finally, (c) what was the precise molecular identity 
of the CaM-like antigen? The following experiments ad- 
dressed each question in turn. 
Purified iNOS Contains No Free CaM.  The purification 
of iNOS from activated RAW 264.7 macrophage-like cells 
involved sequential anion exchange, nucleotide affinity, and 
size exclusion chromatography (12). These steps should each 
militate strongly against the adventitious copurification of 
free CaM, in that iNOS has a predicted pI of 7.7 (11), binds 
to and elutes specifically from 2',5'-ADP-Sepharose,  and has 
a mass of ,x,260-290  kD in its dimeric form (12), while in 
contrast, CaM has a pI of 4.3, is not expected to bind to 
or dute specifically from 2',5'-ADP-Sepharose,  and has a mass 
of 16.8 kD (8-10).  The elution profile in the final gel filtra- 
tion step (Fig. 2) confirms that CaM did not copurify with 
iNOS as a free molecular species, since iNOS purified through 
the first two chromatographic steps displayed no peak corre- 
sponding to free CaM. As illustrated with reagent CaM, any 
free CaM that might have been present at that stage would 
be separated  widely from iNOS (Fig.  2). 
The binding of CaM to CaM-regulated enzymes usually 
requires  elevated  concentrations  of Ca  2+  (8-10).  In  the 
present instance Ca  2+  was not added to any of the buffers 
Figure 1.  Association of CaM-like antigen with iNOS. Purified iNOS 
was boiled and subjected to electrophoresis in the presence of 2%  SDS 
(18) in a 16-crn 10% polyacrylamide gel and immunoblotted with anti- 
CaM mAb (mouse IgG1, 1/~g/ml: Upstate Biotechnology, Lake Placid, 
NY). Lanes I  and 3, iNOS (500 ng); lanes 2 and 4, bovine brain CaM 
(500 ng); lanes l  and 2, amido black stain;  lanes 3 and 4, immunoblot 
with anti-CaM mAb. Migration of markers is indicated at the left in kD. 
Antibody binding was detected with 1:1,000 alkaline phosphatase-con- 
jugated rabbit anti-mouse IgG (Boehringer Mannheim Biochemicals, In- 
dianapolis, IN). 
~  / 
/' 
I 
i  I  Is-  ￿9  ,~  ,-"" 
Q 
o 
O  CaM 
30  ,~o  s'o  10  7'o  s'o  .o 
Retention time, min 
Figure 2.  Final step in the purification ofiNOS (12) by TSK G3000SW 
size-eaclusion chromatography (Pharmacia LKB, Piscataway, NJ). Partially 
purified iNOS lacks a CaM peak. The iNOS dimer elutes at ,x,260--290 
kD, well separated from any free CaM (16.8 kD) that may be present below 
the limit of detection. The latter would elute as shown for bovine brain 
CaM (Sigma  Chemical Co., St. Louis,  MO). 
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sensitive method available, graphite furnace atomic absorp- 
tion spectroscopy (17), the Ca  2+ concentration in the buffer 
used for the final chromatographic step was 39 nM. 
Thus, iNOS and a CaM-like antigen coeluted as a 260-290- 
kD complex at a Ca  2+ concentration below that found in 
resting cells. 
The CaM-like  Antigen Is Noncoualently  Attached.  Most of 
the iNOS-associated CaM was displaced  from the enzyme 
by SDS-PAGE. To exclude the possibility that the reactivity 
of anti-CaM mAb with D0-kD iNOS reflected a covalent 
attachment of residual CaM, we used the procedure employed 
by Cohen et al. (20) to demonstrate that CaM is a noncova- 
lently attached  subunit  of phosphorylase kinase,  namely, 
boiling in the presence of 1 mM EDTA, 15 mM 2-ME, and 
200 mM NaC1. Under these conditions, iNOS disappeared 
from the fluid phase (Fig. 3 B, compare lane 2 with lane I) 
and appeared in the precipitate (Fig. 3 B, lane 3), having lost 
its reactivity with anti-CaM mAb (Fig. 3 A, compare lane 
3 with lane I). We could also remove all detectable CaM-like 
antigen from iNOS by electrophoresis in 2.5 M  urea with 
0.9 M acetic acid (pH 3) (H. Cho, unpublished observations). 
Thus, the association of the CaM-like antigen with iNOS 
was exclusively noncovalent. 
CaM is a heat-resistant protein (8-10). Under the condi- 
tions used to boil iNOS, reagent CaM remained partially in 
solution (H. Cho, unpublished observations). Likewise, when 
iNOS was boiled with EDTA/2-ME/NaC1, the supernatant 
as well as the precipitate contained a protein that comigrated 
with CaM and reacted with anti-CaM mAb (Fig. 3 A, lanes 
2  and 3).  This provided a source of CaM-like antigen for 
further characterization. 
Ident/ficat/on  as CaM.  The supematant generated by boiling 
purified iNOS in EDTA, as analyzed by reverse phase HPLC, 
was a pure solution of a molecule that had the same reten- 
tion time (Fig.  4 A),  tryptic map, and partial amino acid 
sequence (Fig.  4 B)  as authentic CaM (21). 
Finally, when pure iNOS was subjected to reverse phase 
HPLC in 0.1% TFA, two peaks were resolved (Fig.  4 C). 
After protease digestion, the second peak yielded >120 pep- 
tides that matched the amino acid sequence deduced from 
iNOS cDNA (11), but no peptides homologous to CaM (21). 
In contrast, the first peak, when subjected to dectrospray 
ionization mass spectrometry, gave the series of multiply 
charged ions expected for CaM,  and no other peaks  (Fig. 
4 D).  In two such experiments, computer analysis yielded 
values of 16,791 and 16,793 for the average molecular weight 
of this pure molecule. This compares to a theoretical molec- 
ular weight for N-acetylated, lysine-trimethylated CaM of 
16,791.5. 
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Figure 3.  Noncovalent associa- 
tion of a CaM like antigen with 
iNOS. (A) Western blot with anti- 
CaM mAb after electrophoresis  in 
an 8-era gel. Lane  I, pure iNOS 
(500  ng);  lane 2,  supematant  re- 
maining after iNOS was boiled for 
2  rain in  1  mM EDTA,  15  mM 
2-ME, 50 mM Tris, 200 mM NaC1, 
pH 7.0 (19); lane 3, precipitate of 
boiled iNOS; lane 4, bovine brain 
CaM  (500  ng).  (B) Western blot 
with anti-iNOS IgG (1:1,000) (11). 
The samples are the same as in (A). 
Degradation products that appear 
on freezing and thawing of purified 
iNOS are evident in lanes 1 and 3. 
Freshly purified iNOS shows only 
one to three band(s) tightly  clustered 
at D0-kD after staining with amido 
black (see Fig. 2) or silver (see ref- 
erence  12). Although one peptide 
resulting from iNOS degradation 
migrated near the dye front in a po- 
sition similar to reagent CaM, this 
product  could  clearly be  distin- 
guished from CaM, since its migra- 
tion  was  different  from  that  of 
CaM,  and  since  anti-iNOS  was 
completely nonreactive with CaM 
(lanes 2 and 4)~ Antibody binding 
was detected with 1:1,000 alkaline 
phosphate-conjugated rabbit anti- 
mouse IgG (A), or 1:1,000 tht~ 
anti-rabbit  IgG  (B)  (Boehringer 
Mannheim Biochemicals). A  B 
reagent CaM 
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Figure 4.  Identification of tke CaM-like antigen of iNOS as CaM. (A and B) Reverse phase HPLC dution profiles of supernatant of purified iNOS 
boiled in EDTA/2-ME/Tris/NaC1 as in Fig. 2. (A) Identical retention times (C4 column developed with 0.1% TFA in 15-75% acetonitrile). Upper 
trace is for bovine brain CaM; lower trace is for iNOS-derived sample. (B) Tryptic map of iNOS-derived sample from A (C18 column developed with 
0.1% TFA in 2-16%  acetonitrile). The indicated peaks were sequenced by Edman degradation. Peak 6 corresponds to residues 91-94 from CaM; 
peak 8 corresponds to residues  14-21; peak 10 is presumed to contain the blocked NH2-terminus of CaM (20).  (C) Reverse phase capillary HPLC 
of nondenatured iNOS (0.16-mm  internal diameter C4 column developed with 0.1% TFA in 80%  acetonitrile). The eluate passed directly into the 
mass spectrometer as described in reference 11. (D) Electrospray  mass spectrum of the first peak in C. The spectrum was comprised of a series of 
ions consistent with CaM bearing from 9 to 14 positive charges, as indicated in parenthesis (ra/z ratios for the  + 1 through  + 8 charge states of CAM 
would exceed, 2,000,  the upper limit of observation). (Inset) The observed spectrum was collected and analyzed by Finnegan MAT's BIOMASS data 
reduction software,  yielding a molecular weight of 16,791 (16,793 in a repeat study), 
Discussion 
Within their host cells, the two known types of NOS (1) 
produce NO over periods of time and in total quantities that 
differ by several  orders of magnitude. Thus, iNOS and cNOS 
play strikingly different physiologic roles. This study reveals 
one aspect of the molecular basis for this dichotomy, namely, 
the surprising  finding that CaM is a subunit of enzymati- 
cally active iNOS. CaM binds iNOS tightly but noncova- 
lently, without a requirement for elevation of Ca  2+  above 
the concentrations  found in resting cells. The molecule as- 
sociated with iNOS was definitively identified as CaM on 
the basis of its reactivity with anti-CaM mAb, migration on 
SDS-PAGE, retention time on reverse phase HPLC,  tryptic 
map, partial amino acid sequence, and exact molecular mass 
as determined by dectrospray ionization mass spectroscopy. 
To our knowledge, only three other enzymes bind CaM 
constitutively,  that is,  in an apparently  Ca2+-independent 
manner.  These are phosphorylase  kinase (20,  22),  a cyclic 
nudeotide phosphodiesterase (23), and the adenylyl cyclase 
of Bordetella pertussis (24). While the CaM associated with 
iNOS  was  abundant,  we  have not  yet  determined the 
stoichiometry of the complex,  nor have we quantified  the 
affinity of iNOS for CaM, since all the procedures we have 
devised to remove CaM from iNOS have denatured iNOS 
irreversibly. 
Reactivity of the 130 kD region of dectrophoregrams of 
pure iNOS with a highly specific anti-CaM mAb raised the 
possibility that iNOS might contain a covalently embedded 
CaM-like domain, as does a recently described kinase from 
soybean (25). This explanation was eliminated when we de- 
termined the nucleic acid and amino acid sequences of iNOS 
(11) Moreover, two different procedures abolished the ability 
of anti-CaM  mAb to immunoblot iNOS, while preserving 
the reactivity of the mAb with CaM itself. Thus, there is 
no CaM-like epitope intrinsic to iNOS.  It is difficult to ex- 
plain why anti-CaM mAb reacted not only with the 16.8-kD 
species released from iNOS, but also with 130-kD iNOS 
monomers themselves. Two possibilities can be considered. 
First, the mAb may have fortuitously crossreacted with an 
epitope in iNOS other than CaM. This seems unlikely, since 
boiling iNOS in EDTA abolished its reactivity with anti- 
CaM mAb, while boiling iNOS in SDS did not. Thus, the 
putative crossreactive epitope would have to be sensitive to 
EDTA. Alternatively, a portion of the CaM associated non- 
covalently with iNOS may have persisted in its association 
after boiling in SDS and electrophoresis, treatments that nor- 
mally disrupt noncovalent bonds (26). If so, it is surprising 
that the apparent mass of the iNOS-CaM complex was the 
same as the apparent mass ofiNOS stripped of  its CaM (com- 
pare Fig. 3 A, lane I, with Fig. 3 B, lane 3). Perhaps a con- 
formational change in the complex conferred anomalous dec- 
trophoretic behavior. 
NOS purified from cells other than macrophages requires 
200-400 nM added Ca  2  + for half-maximal activity (reviewed 
in reference 1). Similarly, conventional CaM-enzyme com- 
plexes typically bind Ca  2+  with dissociation  constants  of 
400-1,100 nM (27, 28). These concentrations  of Ca  2+  ex- 
ceed the levels in resting calls (70-100 nM) (8), so that the 
activity  of most CaM-dependent enzymes is regulated by 
Ca  2+ transients. In contrast,  CaM associates with iNOS at 
Ca  2+ concentrations  in the range of 39 riM. Thus, CaM is 
likely to complex with iNOS during or promptly after the 
translation  of iNOS mRNA, even in cells whose Ca  2  + re- 
mains at the resting level. This may explain why iNOS ap- 
pears to be tonically active once induced. 
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of its  functions  in  yeast without  binding  Ca  2+  (29).  A 
CaM-dependent  kinase in neuronal cells can become Ca  2  + 
independent after undergoing phosphorylation (30). A neu- 
rospecific, nonenzymatic CaM-binding protein binds CaM 
more tightly in the absence than in the presence of flee Ca  2+ 
(31).  Further work is necessary to determine whether  the 
CaM-iNOS complex binds Ca  2+ , and if so, whether Ca  2+ 
binding plays a role in the formation,  stabilization,  and/or 
enzymatic  activity of the complex. 
In summary, the results of the present study suggest that 
divergent CaM-binding sequences in iNOS (11) and cNOS 
(14, 15) may result in radical differences in the regulation of 
these enzymes,  and thus in their physiologic roles. 
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